Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2.

Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM.

J Biol Chem. 1998 Jul 17;273(29):18514-21.

2.
3.

The angiopoietin-tie2 system in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosis.

Kim I, Moon SO, Han CY, Pak YK, Moon SK, Kim JJ, Koh GY.

Cardiovasc Res. 2001 Mar;49(4):872-81.

PMID:
11230987
4.

Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.

Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP, Alitalo K, Dumont DJ, Yancopoulos GD, Stewart DJ.

Cardiovasc Res. 2001 Feb 16;49(3):659-70.

PMID:
11166279
5.
6.

Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor.

Satchell SC, Harper SJ, Tooke JE, Kerjaschki D, Saleem MA, Mathieson PW.

J Am Soc Nephrol. 2002 Feb;13(2):544-50.

7.

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD.

Science. 1997 Jul 4;277(5322):55-60.

8.

Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.

Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM.

Circ Res. 1998 Aug 10;83(3):233-40.

9.

Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis.

Giuliani N, Colla S, Lazzaretti M, Sala R, Roti G, Mancini C, Bonomini S, Lunghi P, Hojden M, Genestreti G, Svaldi M, Coser P, Fattori PP, Sammarelli G, Gazzola GC, Bataille R, Almici C, Caramatti C, Mangoni L, Rizzoli V.

Blood. 2003 Jul 15;102(2):638-45. Epub 2003 Mar 20.

10.
11.

Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts.

Scott BB, Zaratin PF, Colombo A, Hansbury MJ, Winkler JD, Jackson JR.

J Rheumatol. 2002 Feb;29(2):230-9.

PMID:
11838839
12.

Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes.

Otani A, Takagi H, Oh H, Koyama S, Matsumura M, Honda Y.

Invest Ophthalmol Vis Sci. 1999 Aug;40(9):1912-20.

PMID:
10440243
13.

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD.

Cell. 1996 Dec 27;87(7):1171-80.

14.

Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.

Currie MJ, Gunningham SP, Han C, Scott PA, Robinson BA, Harris AL, Fox SB.

Clin Cancer Res. 2001 Apr;7(4):918-27.

15.

Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.

Singh H, Milner CS, Aguilar Hernandez MM, Patel N, Brindle NP.

Cell Signal. 2009 Aug;21(8):1346-50. doi: 10.1016/j.cellsig.2009.04.002. Epub 2009 Apr 17.

PMID:
19376222
16.

Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells.

Sato A, Iwama A, Takakura N, Nishio H, Yancopoulos GD, Suda T.

Int Immunol. 1998 Aug;10(8):1217-27.

PMID:
9723709
17.

Autocrine/paracrine role of the angiopoietin-1 and -2/Tie2 system in cell proliferation and chemotaxis of cultured fibroblastic synoviocytes in rheumatoid arthritis.

Takahara K, Iioka T, Furukawa K, Uchida T, Nakashima M, Tsukazaki T, Shindo H.

Hum Pathol. 2004 Feb;35(2):150-8.

PMID:
14991531
18.

The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2.

Hughes DP, Marron MB, Brindle NP.

Circ Res. 2003 Apr 4;92(6):630-6. Epub 2003 Feb 27.

19.

Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2.

Marron MB, Singh H, Tahir TA, Kavumkal J, Kim HZ, Koh GY, Brindle NP.

J Biol Chem. 2007 Oct 19;282(42):30509-17. Epub 2007 Aug 29.

20.

Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis.

Milner CS, Hansen TM, Singh H, Brindle NP.

Microvasc Res. 2009 Mar;77(2):187-91. doi: 10.1016/j.mvr.2008.09.003. Epub 2008 Sep 20.

PMID:
18848573

Supplemental Content

Support Center